Cytomegalovirus reactivation in low-grade B-cell lymphoma patients treated with bendamustine

Noriko IsonoDepartment of Hematology, Tokyo Women’s Medical University, Tokyo, Japan;

Yoichi ImaiDepartment of Hematology, Tokyo Women’s Medical University, Tokyo, Japan; Correspondence[email protected]

Aya WatanabeDepartment of Hematology, Tokyo Women’s Medical University, Tokyo, Japan;

Keiichi MoriyaDivision of Hematology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan;

Hideto TamuraDivision of Hematology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan;

Koiti InokuchiDivision of Hematology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan;

Chihiro AsanoDepartment of Hematology/Oncology, Tokyo Women’s Medical University Yachiyo Medical Center, Chiba, Japan;

Michihiko MasudaDepartment of Hematology/Oncology, Tokyo Women’s Medical University Yachiyo Medical Center, Chiba, Japan;

Hanae ShimuraDepartment of Hematology, Tokyo Women’s Medical University, Tokyo, Japan;

Kenjiro MitsuhashiDepartment of Hematology, Tokyo Women’s Medical University, Tokyo, Japan;

Hiroshi KazamaDepartment of Hematology, Tokyo Women’s Medical University, Tokyo, Japan;

Hiroki SugimoriDepartment of Health Science, Daito Bunka University, Tokyo, Japan

Toshiko MotojiDepartment of Hematology, Tokyo Women’s Medical University, Tokyo, Japan;

Junji TanakaDepartment of Hematology, Tokyo Women’s Medical University, Tokyo, Japan;

References